Author: Sangeeta Dhir et al. Aim: Bioresorbable vascular scaffolds (BVS) over the years have emerged as a new treatment option in coronary revascularization. There is a limited data on the use of these novel devices in patients with acute myocardial infarction (AMI). The purpose of this study was to evaluate the safety feasibility and efficacy of BVS implantation in patients with AMI.
Methods and Results: 61 patients diagnosed for AMI underwent Absorb BVS device implantation. The mean age of the patients were 56.6 years with 86.89 % males. 34 patients has history of hypertension (HTN, 55.7%) , 3 patients had history of myocardial infarction (MI ,4.91 % ) ,7 patients were diagnosed with unstable angina ( UA ,11%), 34 patients had anterior wall ST elevation myocardial infarction ( AWSTEMI ,55.73%) ,13 with ST segment elevation myocardial infarction ( STEMI,21.31%) , with Killips class 2…
